GSA Capital Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-48,165
| Closed | -$247K | – | 1565 |
|
|
2024
Q3 | $247K | Buy |
+48,165
| New | +$247K | 0.02% | 1324 |
|
|
2023
Q2 | – | Sell |
-133,396
| Closed | -$1.18M | – | 1467 |
|
|
2023
Q1 | $1.18M | Buy |
133,396
+42,793
| +47% | +$378K | 0.12% | 238 |
|
|
2022
Q4 | $692K | Buy |
90,603
+61,901
| +216% | +$473K | 0.09% | 407 |
|
|
2022
Q3 | $204K | Buy |
28,702
+4,457
| +18% | +$31.7K | 0.03% | 1216 |
|
|
2022
Q2 | $196K | Buy |
+24,245
| New | +$196K | 0.03% | 1074 |
|
|
2022
Q1 | – | Sell |
-7,485
| Closed | -$210K | – | 1365 |
|
|
2021
Q4 | $210K | Buy |
+7,485
| New | +$210K | 0.03% | 1182 |
|
|
2019
Q3 | – | Sell |
-6,000
| Closed | -$290K | – | 1355 |
|
|
2019
Q2 | $290K | Buy |
+6,000
| New | +$290K | 0.03% | 1021 |
|